What can clozapine’s effect on neural oscillations tell us about its therapeutic effects? A scoping review and synthesis

[1]  A. Kaye,et al.  Selective Serotonin Reuptake Inhibitors and Clozapine: Clinically Relevant Interactions and Considerations , 2021, Neurology international.

[2]  S. Dursun,et al.  Clozapine: Why Is It So Uniquely Effective in the Treatment of a Range of Neuropsychiatric Disorders? , 2021, Biomolecules.

[3]  B. Pollock,et al.  Contributions of cholinergic receptor muscarinic 1 and CYP1A2 gene variants on the effects of plasma ratio of clozapine/N-desmethylclozapine on working memory in schizophrenia , 2020, Journal of psychopharmacology.

[4]  W. Drinkenburg,et al.  The phosphodiesterase-4 and glycine transporter-1 inhibitors enhance in vivo hippocampal theta network connectivity and synaptic plasticity, whereas D-serine does not , 2020, Translational Psychiatry.

[5]  Andrea Cipriani,et al.  Comparative effects of 18 antipsychotics on metabolic function in patients with schizophrenia, predictors of metabolic dysregulation, and association with psychopathology: a systematic review and network meta-analysis , 2020, The lancet. Psychiatry.

[6]  G. Pearlson,et al.  Intrinsic neural activity differences in psychosis biotypes: Findings from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) consortium. , 2019, Biomarkers in neuropsychiatry.

[7]  M. Okada,et al.  Clozapine Normalizes a Glutamatergic Transmission Abnormality Induced by an Impaired NMDA Receptor in the Thalamocortical Pathway via the Activation of a Group III Metabotropic Glutamate Receptor , 2019, Biomolecules.

[8]  U. Seneviratne,et al.  EEG changes in patients on antipsychotic therapy: A systematic review , 2019, Epilepsy & Behavior.

[9]  J. Coyle,et al.  Glutamate hypothesis in schizophrenia , 2019, Psychiatry and clinical neurosciences.

[10]  A. Minelli,et al.  Treatment-Resistant Schizophrenia: Genetic and Neuroimaging Correlates , 2019, Front. Pharmacol..

[11]  A. Malhotra,et al.  Electroconvulsive Therapy and Schizophrenia: A Systematic Review , 2019, Molecular Neuropsychiatry.

[12]  G. Remington,et al.  Glutamatergic Neurometabolite Levels in Patients With Ultra-Treatment-Resistant Schizophrenia: A Cross-Sectional 3T Proton Magnetic Resonance Spectroscopy Study , 2019, Biological Psychiatry.

[13]  Zachary Munn,et al.  JBI Reviewer's Manual , 2019 .

[14]  K. Kasai,et al.  Electrophysiological evidence for abnormal glutamate-GABA association following psychosis onset , 2018, Translational Psychiatry.

[15]  J. McGowan,et al.  PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation , 2018, Annals of Internal Medicine.

[16]  V. Siskind,et al.  Clozapine Response Rates among People with Treatment-Resistant Schizophrenia: Data from a Systematic Review and Meta-Analysis , 2017, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[17]  C. Thorn,et al.  Effects of M1 and M4 activation on excitatory synaptic transmission in CA1 , 2017, Hippocampus.

[18]  H. Möller,et al.  Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology. , 2017, The American journal of psychiatry.

[19]  R. Barkin,et al.  A systematic review on the impact of psychotropic drugs on electroencephalogram waveforms in psychiatry , 2016, Postgraduate medicine.

[20]  S. Bowyer.  Coherence a measure of the brain networks: past and present , 2016 .

[21]  B. Clemens,et al.  Valproate treatment normalizes EEG functional connectivity in successfully treated idiopathic generalized epilepsy patients , 2014, Epilepsy Research.

[22]  T. Kanbayashi,et al.  Clozapine-induced seizures, electroencephalography abnormalities, and clinical responses in Japanese patients with schizophrenia , 2014, Neuropsychiatric disease and treatment.

[23]  L. Stitt,et al.  Clozapine response and pre-treatment EEG-is there some kind of relationship , 2014, Industrial psychiatry journal.

[24]  T. Kiss,et al.  Rhythmic theta and delta activity of cortical and hippocampal neuronal networks in genetically or pharmacologically induced N-methyl-d-aspartate receptor hypofunction under urethane anesthesia , 2013, Neuroscience.

[25]  D. MacCrimmon,et al.  Clozapine Augments Delta, Theta, and Right Frontal EEG Alpha Power in Schizophrenic Patients , 2012, ISRN psychiatry.

[26]  J. Meador-Woodruff,et al.  Glutamate Receptor Abnormalities in Schizophrenia: Implications for Innovative Treatments , 2012, Biomolecules & therapeutics.

[27]  H. Kashima,et al.  Factors associated with response to clozapine in schizophrenia: a review. , 2011, Psychopharmacology bulletin.

[28]  N. Sugimoto,et al.  Effects of clozapine and N-desmethylclozapine on synaptic transmission at hippocampal inhibitory and excitatory synapses , 2011, Brain Research.

[29]  Vidhi Singh,et al.  Meta-Analysis of the Efficacy of Adjunctive NMDA Receptor Modulators in Chronic Schizophrenia , 2011, CNS drugs.

[30]  F. Barbosa,et al.  Exploring the dynamics of P300 amplitude in patients with schizophrenia. , 2011, International journal of psychophysiology : official journal of the International Organization of Psychophysiology.

[31]  U. Kang,et al.  Effects of Psychotropic Drugs on Quantitative EEG among Patients with Schizophrenia-spectrum Disorders , 2011, Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology.

[32]  David Taylor,et al.  Clozapine-related EEG changes and seizures: dose and plasma-level relationships , 2011, Therapeutic advances in psychopharmacology.

[33]  Pavel Mohr,et al.  LORETA Functional Imaging in Antipsychotic-Naive and Olanzapine-, Clozapine- and Risperidone-Treated Patients with Schizophrenia , 2008, Neuropsychobiology.

[34]  Craig Mallinckrodt,et al.  Selective muscarinic receptor agonist xanomeline as a novel treatment approach for schizophrenia. , 2008, The American journal of psychiatry.

[35]  J. Brewer,et al.  Rechallenging with clozapine following neutropenia: treatment options for refractory schizophrenia. , 2008, The American journal of psychiatry.

[36]  N. Delva,et al.  Clozapine-Induced Seizures: Recognition and Treatment , 2007, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[37]  S. Kapur,et al.  Evaluation of N-Desmethylclozapine as a Potential Antipsychotic—Preclinical Studies , 2007, Neuropsychopharmacology.

[38]  P. Bob.  Dissociation, forced normalization and dynamic multi-stability of the brain. , 2007, Neuro endocrinology letters.

[39]  Benoit Dawant,et al.  Occupancy of Striatal and Extrastriatal Dopamine D2 Receptors by Clozapine and Quetiapine , 2006, Neuropsychopharmacology.

[40]  B. Clemens,et al.  Quantitative EEG effects of carbamazepine, oxcarbazepine, valproate, lamotrigine, and possible clinical relevance of the findings , 2006, Epilepsy Research.

[41]  Andrew Farah,et al.  Atypicality of atypical antipsychotics. , 2005, Primary care companion to the Journal of clinical psychiatry.

[42]  D. Javitt,et al.  Inhibition of System A-mediated glycine transport in cortical synaptosomes by therapeutic concentrations of clozapine: implications for mechanisms of action , 2005, Molecular Psychiatry.

[43]  A. Gross,et al.  Clozapine-induced QEEG changes correlate with clinical response in schizophrenic patients: a prospective, longitudinal study. , 2005, Pharmacopsychiatry.

[44]  A. Coenen,et al.  Effects of diazepam and zolpidem on EEG beta frequencies are behavior-specific in rats , 2004, Neuropharmacology.

[45]  A. Levey,et al.  The role of M1 muscarinic receptor agonism of N-desmethylclozapine in the unique clinical effects of clozapine , 2004, Psychopharmacology.

[46]  M. Maj,et al.  Is the Time Course of Clozapine Response Correlated to the Time Course of Clozapine Plasma Levels? A One-Year Prospective Study in Drug-Resistant Patients with Schizophrenia , 2002, Neuropsychopharmacology.

[47]  V. Knott,et al.  EEG coherence following acute and chronic clozapine in treatment-resistant schizophrenics. , 2002, Experimental and clinical psychopharmacology.

[48]  P. Buckley,et al.  Treatment-refractory schizophrenia , 2001, Current psychiatry reports.

[49]  V. Knott,et al.  Quantitative EEG in schizophrenia and in response to acute and chronic clozapine treatment , 2001, Schizophrenia Research.

[50]  A. Gross,et al.  Marked Clozapine-Induced Slowing of EEG Background Over Frontal, Central, and Parietal Scalp Areas in Schizophrenic Patients , 2001, Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society.

[51]  F. Michel,et al.  Clozapine inhibits synaptic transmission at GABAergic synapses established by ventral tegmental area neurones in culture , 2000, Neuropharmacology.

[52]  E. El-Fakahany,et al.  Clozapine interaction with the M2 and M4 subtypes of muscarinic receptors. , 1999, European journal of pharmacology.

[53]  M. Olianas,et al.  Mixed Agonist–Antagonist Properties of Clozapine at Different Human Cloned Muscarinic Receptor Subtypes Expressed in Chinese Hamster Ovary Cells , 1999, Neuropsychopharmacology.

[54]  D. Javitt,et al.  Effects of clozapine on auditory event-related potentials in schizophrenia , 1998, Biological Psychiatry.

[55]  A. Szegedi,et al.  Pharmacokinetic interactions of clozapine with selective serotonin reuptake inhibitors: differential effects of fluvoxamine and paroxetine in a prospective study. , 1998, Journal of clinical psychopharmacology.

[56]  K. Inui,et al.  Electroencephalographic Findings in Patients with DSM-IV Mood Disorder, Schizophrenia, and Other Psychotic Disorders , 1998, Biological Psychiatry.

[57]  Yves Chaput,et al.  Quantified EEG changes associated with a positive clinical response to clozapine in schizophrenia , 1995, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[58]  H. Meltzer,et al.  Effects of six months of clozapine treatment on the quality of life of chronic schizophrenic patients. , 1990, Hospital & community psychiatry.

[59]  S Manmaru,et al.  Quantification of benzodiazepine-induced topographic EEG changes by a computerized wave form recognition method: application of a principal component analysis. , 1989, Electroencephalography and clinical neurophysiology.